CD8A and neoplasm: Further experiments involved the enrichment of human CD8 T cells cultured in the presence of recombinant hIL-2 for 24 h, followed by assessment of their cytolytic activity against various tumor cell lines, COLO205, HCT-15, BT-549, BT-474, A-375, and LNCaP, as targets.